Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

Founded with a mission to address the “last-mile” challenges in pain relief, Doloromics integrates artificial intelligence ...

New opioid prescriptions for patients in the UK mostly written for musculoskeletal conditions, in which there is little evidence for opioid efficacy.

The battle against breast cancer has produced significant triumphs in recent years, with new and tailored treatments now ...

Health care and tech innovation go hand in hand. From delivering steady streams of medication to speeding up treatment of ...

Envista Holdings Corporation ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conference on Tuesday, December 3, 2024 from 12:30 ? 1:15 pm ET ...

Not everyone with knee, shoulder or hip pain is a good candidate for replacement surgery. Even those who are approved for ...

TNX-102 SL, a sublingual cyclobenzaprine HCl formulation, is safe and effective for treating fibromyalgia symptoms, according to study results presented at the American College of Rheumatology (ACR) ...

It turned out that the nerve she was ... t a one-size-fits-all treatment. “It’s about a personalised approach, where we ...

Eli Lilly and Company announced today that it has elected Jon Moeller as a new member of its board of directors, effective Dec. 1, 2024. In addition, the company announced that Karen Walker will ...